Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025)

Agios Pharmaceuticals' (AGIO) quarterly Change in Taxes came in at -$683000.0 in Q2 2025, down 263.3% on a QoQ basis from -$188000.0 in Q1 2025.

Analysis

Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025) Analysis & Trends

Agios Pharmaceuticals (AGIO) has 6 years of Change in Taxes data on file, last reported at -$683000.0 in Q2 2025.

Quarterly Change in Taxes changed N/A year-over-year to -$683000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$683000.0 (down 200.0% YoY) and the FY2025 annual result came in at -$871000.0, down 200.0% from the prior year.
Change in Taxes fell to -$683000.0 in Q2 2025, from -$188000.0 in the prior quarter.
In the past five years, Change in Taxes ranged from a high of $52.7 million in Q3 2024 to a low of -$51.8 million in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Agios Pharmaceuticals	1.97 Bn	1.97 Bn	41.75 Mn	-

Historic Data

Download Data